TRIUMPH-3 (NCT05882045)

Phase 3, randomised double-blind study of retatrutide versus placebo in participants with severe obesity and established cardiovascular disease. Status: completed (actual completion 2026-05-14); no structured results record posted to ClinicalTrials.gov yet, and this Record entry does not carry any topline efficacy or cardiovascular-outcome figures for TRIUMPH-3 — not yet independently verified for publication here.